Home Mobile games Living community 5G technology Commercial street Fashion icon More

Yiling Pharmaceutical Lianhua Qingwen capsules are widely used in China against the epidemic

2020-04-18

SHIJIAZHUANG, China, April 13, 2020 --- Wu Xiangjun, general manager of Yiling Pharmaceutical co., LTD., announced that Lianhua Qingwen capsules (granules) have been recommended by the National Health Commission and the State Administration of Traditional Medicine of China. The ministry of foreign affairs of the People's Republic of China has specially arranged to purchase 700,000 boxes of Lianhua Qingwen and distribute them to each Chinese embassy. The health packages for Chinese students are also equipped with Lianhua Qingwen.

连花清瘟俄语图片.jpg

On April 9, Yiling Pharmaceutical donated 2 million yuan to the Red Cross foundation of China as an international humanitarian assistance fund against the epidemic, demonstrating the strong sense of social responsibility of the company.

Since the third edition of COVID-19 diagnosis and treatment program was incorporated into the Chinese medicine treatment program, the National Health Commission has continuously improved and optimized the drugs and prescriptions for the prevention and treatment of COVID-19 with traditional Chinese medicine. From different stages of prevention, critical illness and recovery, it is fully involved in the treatment and rehabilitation.

So far, Lianhua Qingwen has been already exported to Canada, Romania, Thailand, Mozambique, Brazil, Indonesia and Hong Kong SAR and Macao SAR. Chinese traditional medicine began to be used all over the world and was recognized by the international community.

After the outbreak of the new epidemic, Yiling Pharmaceutical took the lead in donating Lianhua Qingwen capsules which worth more than 10 million yuan. On March 12, 2016, it donated 1.8944 million yuan and 1.48 million Lianhua Qingwen capsules to the Red Cross society of China to help the epidemic in Iraq and Italy.

Disclaimer: This article is reproduced from other media. The purpose of reprinting is to convey more information. It does not mean that this website agrees with its views and is responsible for its authenticity, and does not bear any legal responsibility. All resources on this site are collected on the Internet. The purpose of sharing is for everyone's learning and reference only. If there is copyright or intellectual property infringement, please leave us a message.

Newest

Jewellery & Gem ASEAN Bangkok (JGAB) 2025: Connecting ASEAN's Gem and Jewellery Business to the Global Market

BioCity Biopharmaceutics Co., Ltd. Announces Clinical Collaboration to Evaluate BC3195 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Locally Advanced or Metastatic Solid Tumors

Acer Reports FY2024 Net Income of NT$5.54 Billion and NT$1.7 Cash Dividend Per Share

Ping An #1 in Brand Finance's Global Insurance Brand Value for 9th Year, Brand Value Reaches $33.6 Billion

LITEON Showcase Groundbreaking Energy Savings in Private 5G Network with NTT EAST at MWC 2025

2025 Global Sources Hong Kong Shows: Shaping the Future of Consumer Trends and Redefining Sourcing

©Copyright 2009-2020 Startup Weekly    Contact Us  SiteMap